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An automated device for defibrillation using a vertical
shock pathway (tongue-epigastric or tongue-apex) has
been developed. The energy requirements for defibril-
lation using vertical pathways are uncertain and will be
determined largely by the impedance of the pathway.
The purpose of this study was to determine the imped-
ance characteristics of vertical defibrillation pathways
in human subjects. Twenty patients undergoing elective
cardioversion of atrial fibrillation or atrial flutter, or
both, were studied. Patients received shocks from elec-
trodes placed in tongue-epigastric or tongue-cardiacapex
positions. The tongue electrode was a 12em' metal plate
fixed to a standard plastic oropharyngeal airway. The
epigastric or cardiac apex electrode was a 40 em' self-
adhesive pad. The electrodes were connected to a stan-
dard damped-sinusoidal waveform defibrillator.
It was found that the two vertical shock pathways
had substantially higher impedance than the standard
Survival of patients who develop ventricular fibrillation is
markedly enhanced by rapid defibrillation performed by par-
amedical personnel (1,2). The training of lay and paramed-
ical personnel in techniques of arrhythmia recognition and
standard transthoracic defibrillation is feasible, but is lengthy
and expensive. There is considerable interest, therefore, in
automated devices that could diagnose ventricular fibrilla-
tion and rapidly defibrillate with only minimal operator par-
ticipation. Such devices require a good quality electrocar-
diographic signal for automated analysis; the signal must be
quickly obtainable. Mucous membranes, such as the tongue,
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transthoracic pathway: tongue-epigastric pathway 130
± 110 (SD), tongue-apex pathway 115 ± 120, trans-
thoracic pathway 68 ± 110 (p < 0.05). The higher
impedance is probably due to the longer interelectrode
distances of vertical pathways: tongue-epigastric 33 ±
3 em, tongue-apex 28 ± 3 cm, transthoracic 23 ± 3 em
(p < 0.05). Vertical pathway shocks were successful in
the cardioversion of 15 of 20 patients. Four of the five
patients in whom vertical shocks were unsuccessful sub-
sequently underwent successful cardioversion by trans-
thoracic shocks;the transthoracic shocksachieveda higher
current because of lower impedance of the transthoracic
route.
It is concluded that vertical shock pathways in human
subjects have higher impedance than do transthoracic
pathways. Because of this higher impedance, higher en-
ergy may be required for vertical pathway defibrillation
than for standard transthoracic defibrillation.
may provide such a signal. Could the tongue also be used
as a site for defibrillation? A tongue-cardiac apex pathway
for defibrillation was described by Prevost and Batelli (3)
over 80 years ago. More recently, a tongue-epigastric path-
way has been evaluated in animals (4,5) and has also been
used for initial trials of human defibrillation and cardio-
version with an automated device (6-8).
Although initial successes have been reported when using
such vertical shock pathways to defibrillate, the data are
limited. In particular, the energy that should be selected for
defibrillation using a vertical pathway is uncertain. An ad-
equate current flow must be achieved to defibrillate (9,10);
current is determined by the energy selected and the imped-
ance of the pathway. Reports of vertical pathway impedance
in animals disagree. In dogs, Rosborough (4) found that a
tongue-epigastric pathway had only a slightly higher imped-
ance than did a standard transthoracic (parasternal to apex)
pathway, whereas we (5) found that tongue-epigastric
impedance was markedly higher than transthoracic imped-
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ance with a corresponding increase in defibrillation energy
requirements. In any event, comparisons of vertical and
transthoracic pathway impedance in dogs may not be di-
rectly applicable to human subjects because of marked dif-
ferences in thoracic geometry between the two species (the
human chest is much broader than the dog chest). Because
there is, at present, no information available about the
impedance characteristics of vertical defibrillation pathways
and because impedance is a key determinant of the energy
requirements for defibrillation, we undertook an investi-
gation to determine vertical pathway impedance in patients.
Methods
Studypatients. We studied 20 patients with either atrial
fibrillation or atrial flutter. Elective cardioversion had been
recommended for these patients for standard clinical indi-
cations by physicians not involved in this investigation. The
study was approved by the University of Iowa Human Re-
search Committee. All patients received a full oral and writ-
ten explanation and all gave informed written consent.
Equipment. All shocks were QRS-synchronized and were
administered from a critically damped sinusoidal waveform
defibrillator (Datascope MD2J). This defibrillator displays
delivered energy (in joules) based on the standard clinical
assumption of a 50 n resistance before each shock and peak
current flow (in amperes) after each shock. The current was
recorded and, using methods previously described by us
(11), the delivered energy and resultant current flow were
used to determine interelectrode impedance for first shocks
of 100 joules.
The tongue-epigastric/tongue-apex shocks were per-
formed using a tongue electrode that consisted of a 12 cnr'
(2 X 6 em) metal plate fixed to a standard oropharyngeal
plastic airway. This was positioned in the oropharynx after
the patient was anesthetized, with the metal plate resting
against the posterior portion of the tongue. The jaws were
held closed by a mask-strap device to assure good tongue-
electrode contact. The other electrode was an 8 ern diameter
(50 ern") circular, gelled, self-adhesive pad previously re-
ported by us (12) to have an impedance similar to that of
standard hand-held paddle electrodes. In alternate patients,
this pad was placed either on the epigastrium or over the
palpable cardiac apex. The electrodes were connected to the
defibrillator using a custom-made adaptor modified from an
adaptor normally used with internal (open chest surgical)
defibrillator paddle electrodes. The impedance of both ca-
bles of this adaptor was less than 1 n on bench testing.
Before the anesthesia and shock delivery, we used a tape
measure to determine the interelectrode distance. The thy-
roid cartilage was assumed to represent the most caudal
position of the tongue electrode; the distance from this point
to the most cephalad edge of the epigastric or apex electrode
was measured. For comparative purposes, we placed stan-
dard transthoracic paddle electrodes on the chest where they
would ordinarily be placed for standard anterolateral car-
dioversion (one paddle on the upper right parasternal area
and the other at the cardiac apex), and similarly measured
the shortest distance between the chest electrodes.
We recorded the electrocardiogram from standard small
"paste-on" disc electrodes, choosing the monitoring lead
that yielded the highest amplitude electrocardiographic sig-
nal. In 13 patients, we also recorded an electrocardiogram
from the tongue-epigastric/tongue-apex electrode pair.
Energy protocols. For atrial fibrillation, we began shocks
at 100 J with subsequent shocks of 200 and 300 J if nec-
essary. No shock to the tongue of higher than 300 J was
attempted. For atrial flutter, we began shocks at 20 J, with
subsequent shocks at 40 J if necessary. If a shock given for
atrial flutter produced atrial fibrillation, we immediately
changed to the atrial fibrillation protocol, giving the next
shock at 100 J. If vertical pathway shocks up to 300 J failed
to terminate the arrhythmia, we immediately changed to
standard transthoracic anterolateral paddle electrodes, be-
ginning again at 100 J, then if necessary to 200, 300 and
400 J.
Tissue damage. Before beginning the procedure, we
examined each patient's mouth carefully for preexisting ab-
normalities. We reexamined each patient after all shocks
were completed, searching for abrasions, ecchymoses or
other evidence of damage related to the tongue electrode.
If any of these were found, the lesion was noted. We also
reexamined all patients the next day to search for later ap-
pearing lesions and determine changes in lesions that ap-
peared immediately after the procedure.
Anesthesia. All patients were fasting for at least 6 hours
before the procedure. Anesthesia was accomplished by ad-
ministering 1.1 mg/kg of intravenous methohexital as a slow
bolus injection after 5 minutes of preoxygenation with 100%
oxygen. During this preoxygenation period, 2 to 4 mg of
intravenous diazepam was also administered slowly for pre-
medication if the patient appeared anxious. The first shock
was administered when the patient became apneic and lost
the eyelash reflex. If spontaneous respiration and the lash
reflex returned before a second or third shock was needed,
half the initial methohexital dose was repeated. Where ap-
propriate, positive pressure bag/mask ventilation was per-
formed after the shocks were completed until spontaneous
respiration returned.
No attempt was made to interfere with or alter cardiac
drug regimens previously chosen by the patient's physician.
We did not administer any antiarrhythmic drugs, such as
lidocaine or propranolol, during the procedure.
Statistical analysis. This was done using standard tech-
niques. The impedances and the relative lengths of the tongue-
epigastric, tongue-apex and transthoracic pathways were
compared by analysis of variance. After it was determined
that there were significant (p < 0.05) differences in the
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impedances of the three pathways and in the distances of
the pathways, specific differences between the pathways
were identified using pair-wise analysis (Tukey's test). All
data are expressed as mean ± standard deviation,
Results
Twenty patients were studied. Three patients with atrial
fibrillation who were initially converted to sinus rhythm
subsequently relapsed into atrial fibrillation and underwent
a second cardioversion. In those patients who required a
second cardioversion, the vertical pathway alternate to the
one previously used was selected. For example, if the tongue-
apex route was used the first time, the tongue-epigastric
route was selected the second time. Sixteen patients had
atrial fihrillation initially and four patients had atrial flutter;
two of these developed atrial fibrillation during the car-
dioversion procedure and received additional shocks for atrial
fibrillation. Thus, a total of 18 patients ultimately received
vertical pathway shocks for atrial fibrillation. Because three
patients required a repeat cardioversion later, a total of 21
separate cardioversions for atrial fibrillation were attempted,
Energy, current and success rates (Table 1). Of the
18 patients who received shocks for atrial fibrillation, in 13
the arrhythmia was converted to sinus rhythm. In the re-
maining five patients with atrial fibrillation the arrhythmia
failed t< I convert to sinus rhythm with vertical pathway shocks
up to 300 J, Four of these five patients subsequent expe-
rienced conversion when shocks were administered from
standard transthoracic anterolaterai paddles: three with con-
version to sinus rhythm and one to atrial tachycardia with
2:1 atroventricular block, Each of these four patients re-
quired 200 J shocks from the transthoracic paddles to con-
vert, In each patient, the current generated by the 200 J
transthoracic shocks exceeded the current generated by 300
J vertical pathway shocks. The arrhythmia of all four pa-
tients with atrial flutter was converted; in two to sinus rhythm
directly (both at 20 J) and in two to atrial fibrillation (in
one at 20 J and in one at 40 J).
Impedance characteristics of vertical pathways (Fig.
1). The first shock impedance ofthe tongue-epigastric path-
way was 130 ± 11 n (range 106 to 140), The impedance
of the tongue-apex pathway was 115 ± 12 n (range 95 to
130), and in the five patients who received shocks from
transthoracic electrodes (after vertical pathway shocks failed),
the mean impedance was 68 ± 11 n (range 54 to 78).
Analysis of variance followed by pair-wise analysis showed
each of the three pathway impedances to be significantly (p
< 0.05) different from the other. The relative lengths of
the vertical pathways and the transthoracic pathway were:
tortgue-epigastric, 33 ± 3 em; tongue-apex, 28 ± 3 em
and transthoracic, 23 ± 3 em. Again, each of the three
pathway distances was significantly (p < 0.05) different
from the other.
Tissue damage. We observed an ecchymotic area on
the soft palate in one patient immediately after cardiover-
sion, In two other patients, white palatal discolorations ap-
peared the day after the cardioversion. In a fourth patient,
we noted a tan tongue discoloration (without swelling) cor-
responding to location of the metal plate. In each of these
four patients, the lesions faded rapidly and were gone within
several days. All four patients complained of mild to mod-
erate mouth soreness, No patient complained of severe dis-
comfort or difficulty in breathing; all were able to talk and
eat normally after the procedure. No patient experienced
pharyngeal or laryngeal spasm or marked swelling of the
tongue.
We observed lip or anterior tongue abrasions in three
patients. The location of these lesions suggested that they
were more likely due to biting the plastic airway during the
Table 1. Relation Between Energy, Current and Success Rates in Cardioversion of Atrial
Fibrillation (21 cardioversion attempts)
Electrode Energy Current No, of Successes
Position (1) (A) (cumulative %)
Tongue-epigastric (n = \0)
100 16 ± 2 3 (30)
200 24 + 2 4 (70)
300 27 ± 2 0(70)
Tongue-apex (n = II)
\00 20 ± 3 3 (27)
200 26 ± 2 5 (73)
300 35 ± 2 0(73)
Transthoracic (n = 5)
\00 26 ± 2 0(0)
200 39 ± 4 4 (80)
300* 39* 0(80)
400* 46* 0(80)
*Only one patient received shocks of 300 and 400 joules,
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tetanic spasm induced by the shock, rather than to passage
of the current itself. These lesions healed within several
days.
Circular erythematous skin lesions were uniformly ob-
served where the epigastric/cardiac apex self-adhesive pads
had been placed . These were similar to the skin lesions seen
after cardioversion with standard transthoracic paddles. In
general , they were mildly tender.
Discussion
The main finding of this investigation is that vertical
shock pathways in human subjects have a higher impedance
than do transthoracic pathways . This is probably due to the
longer interelectrode distance associated with vertical
pathways .
Use of vertical pathways for defibrillation. Why should
a vertical shock pathway be evaluated for defibrillation? We
have already discussed the attractiveness of automated de-
vices for defibrillation that would require minimal operator
training and knowledge. Vertical shock pathways, using the
tongue as one electrode site, have several advantages that
make them attractive for automated defibrillation. First ,
Tongue-Epigastric Elect rodes
Lead II Electrodes
electrocardiographic data can be quickly and easily obtained
from the tongue, and the signal to noise ratio of such data
is high enough to be suitable for automated analysis and
diagnosis of ventricular fibrillation or other arrhythmias. An
example of the good quality electrocardiographic signal we
obtained from the tongue in this study is shown in Figure
2. Second, the pathway allows the use of safety features
that would avoid inappropriate shocks. In the commercially
available version of a vertical pathway defibrillation device
("Heart-Aid," Cardiac Resuscitator Corp.), an air motion
sensor is mounted on the oropharyngeal airway adjacent to
the tongue electrode. A patient truly in ventricular fibril-
lation should have minimal or gasping respirations; if the
air motion sensor detects more movement of air than is
expected, the defibrillation device is automatically disabled
and will not fire. Similarly, a patient with fibrillation should
have a reduced or absent gag reflex; if an active gag reflex
is present, the patient will not tolerate the oropharyngeal
airway and will involuntarily attempt to expel it. The re-
sultant poor electrode-tongue contact will produce a very
high pathway impedance; an impedance sensor in the com-
mercially available device is programmed to react to an
excessively high, unphysiologic impedance in the pathway
Figure 2. Electrocardiograms recorded from tongue-
epigastric electrodes (top) and from standard mon-
itoring electrodes in lead II position (bottom) in
one patient.
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by disabling the defibrillator. These automatic safety fea-
tures avoid inappropriate shocks and would be particularly
important if the device were to be used, as intended, by
minimally trained operator-rescuers . Such rescuers would
probably not be able to distinguish true ventricular fibril-
lation from other causes of collapse which should not be
treated by direct current shocks.
Importance of impedance in selecting energy levels.
To defibrillate, a critical level of current flow must be achieved
(9,10) . Because current flow at any given energy is largely
determined by pathway impedance, knowledge of the
impedance of vertical shock pathways becomes critical in
choosing appropriate energy levels for a vertical defibrillator
device. Thus, once effectiveness in animals was demon-
strated (4,5), determining vertical defibrillation pathway
impedance in human subjects was the next appropriate step
in the development of an automated defibrillator. We chose
to do this in patients receiving shocks for atrial arrhythmias
rather than for ventricular fibrillation for two reasons . First,
data collection of any type is far more accurate during the
cardioversion of atrial arrhythmias, usually performed elec-
tively under well controlled conditions rather than during
emergency ventricular defibrillation. Second, concerns about
cardiac toxicity from excessive energy and current mandated
the use of relatively low energy shocks initially, at least
until some human impedance data were obtained (13). Such
low energy shocks are suitable for elective cardioversion,
since if the first low energy shock fails to restore sinus
rhythm. subsequent shocks at higher energies are usually
effective. The modest delay in elective cardioversion in-
curred in the use of a low initial energy protocol is not
critical, whereas such delays in terminating ventricular fi-
brillation would be intolerable.
Determinants of impedance. Determinants of imped-
ance to electrical current flow in defibrillation and cardio-
version have previously been studied in detail. A major
determinant of transthoracic impedance in dogs and human
SUbjects is the transthoracic interelectrode distance (II).
Our findings in this study of vertical pathway impedance
also suggest that vertical interelectrode distance is critical.
We showed that the pathway with the highest impedance
(the tongue-epigastric pathway) corresponded to the longest
interelectrode pathway, while the shortest pathway (trans-
thoracic pathway) had the lowest impedance. The tongue-
apex pathway was characterized by intermediate distance
and intermediate impedance.
Other factors influencing impedance were probably less
important , Transthoracic impedance is reduced by using a
larger electrode (11) , but using a larger tongue electrode in
our canine study (5) caused an insignificant reduction in
tongue-epigastric impedance. Good electrode tissue contact
was achieved in the present study by using a mask-strap
device to firmly press the metal plate against the tongue.
The other electrode was a self-adhesive pad of a type pre-
viously shown by us (12) to have an impedance similar to
that of standard "paddle" electrodes.
Cardioversion or defibrillation is accomplished by the
passage of a sufficient amount of current to depolarize a
critical amount of myocardium (9, 10). It appears that each
patient has a critical current level above which the chances
of converting to sinus rhythm are high. This point is well
demonstrated by the five patients whose arrhythmia was not
converted with vertical shocks. After vertical shocks failed
in these patients, the first transthoracic shock (100 J) gen-
erated a current flow in each patient that was lower than the
highest current achieved by the series of shocks from vertical
electrodes; this first transthoracic shock failed to convert in
every case. The second transthoracic shock (200 J) achieved
in each patient a current higher than any of the previous
vertical pathway shocks, and this shock effected conversion
in four of the five patients (Table 1). The arrhythmia of
these four patients would probably have ultimately con-
verted with vertical pathway shocks, but a higher energy
than 300 J would have been necessary to overcome the
higher vertical impedance and generate adequate current.
Tissue damage. We did not encounter significant tongue
or other oral damage using tongue electrodes. This is in
agreement with previous animal studies described by us (5)
and others (4) and with initial observations in human sub-
jects (6,8) at energies up to 320 J (8).
Implications for emergency defibrillation. The data
from atrial cardioversion cannot be extrapolated directly to
the treatment of ventricular fibrillation , which involves a
larger mass of myocardium and is often associated with
severe metabolic disturbances (14). However, the fact that
the impedance of vertical pathways is up to two times higher
than that of the transthoracic route suggests that energies in
the range of 200 J, which several groups (14,15) have re-
ported effective for defibrillation by way of transthoracic
electrodes, may not be adequate to defibrillate when applied
through a high impedance vertical pathway. The commer-
cially available "Heart-Aid" vertical pathway defibrillation
device has delivered energy settings of 200 and 335 J. Whether
335 J will be sufficient to overcome the high vertical path-
way impedance and achieve defibrillation can only be de-
tennined by further clinical testing in patients with ventric-
ular fibrillation.
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